| HOME >> MEDICINE >> TECHNOLOGY |
in Treatment-Naïve Patients II-47
GSK and Pfizer Launch ViiV Healthcare II-47
GSK and Idenix to Co-Develop New HIV Drug II-48
Avexa Enters into Agreement with Tibotec II-48
Gilead Enters into Agreement with Piramal Lifesciences II-49
Avexa to Merge with Progen II-49
Myriad Acquires Bevirimat II-49
Vironova Signs Agreement with UMBC II-49
Ceragenix Signs License Agreement with FPBT II-49
Medivir to Transfer Alovudine License and IP to Beijing Mefuvir II-50
Gilead Sciences and Merck Ink Distributing Agreement for Atripla II-50
Boehringer Commences New Clinical Trial for Viramune® XR II-51
EC Reinstates Marketing Authorization for Viracept II-51
Virax Bags Additional Patent for HIV Vaccine, VIR201 II-51
6. FOCUS ON SELECT GLOBAL PLAYERS II-52
Abbott Laboratories (US) II-52
Boehringer Ingelheim GmbH (Germany) II-52
Bristol-Myers Squibb Company (US) II-53
F. Hoffmann-La Roche Ltd. (Switzerland) II-54
Gilead Sciences, Inc. (US) II-54
Koronis Pharmaceuticals, Inc. (US) II-55
Merck & Co., Inc. (US) II-55
Pfizer, Inc. (US) II-56
Tibotec BVBA (Belgium) II-
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |